Akebia Therapeutics

AKBANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$260.064 M

$0.94 +2.49%

Close of 21 Sept 2026

Revenue

$236.2M

#2236 by revenue

Earnings

-$5.30M

Loss-making

Shares outstanding

277,106,245

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#248MacrogenicsMGNX$262.4M
#249Camp4 TherapeuticsCAMP$261.7M
#250Akebia TherapeuticsAKBA$260.1M
#251Entrada TherapeuticsTRDA$258.5M
#252Bicycle TherapeuticsBCYC$254.1M

What if Akebia Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$109,250.71

Per share 116,410× higher

Bitcoin $1.72T

$6,206.30

Per share 6,613× higher

Nvidia $5.48T

$19,775.30

Per share 21,071× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Akebia Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.